Sep 01, 2021 4:05pm EDT NeuBase Therapeutics to Present Virtually at the H.C. Wainwright 23rd Annual Global Investment Conference
Aug 12, 2021 4:01pm EDT NeuBase Therapeutics Reports Financial Results for the Third Quarter of Fiscal Year 2021 and Recent Operating Highlights
Jun 08, 2021 12:30pm EDT NeuBase Therapeutics Demonstrates Functional Rescue in Myotonic Dystrophy Type 1 Model and Allele-Selective Inhibition of KRAS Mutations to Inhibit Tumor Growth
Jun 02, 2021 9:00am EDT NeuBase Therapeutics Announces Speakers for Virtual R&D Day Taking Place on June 8th
May 25, 2021 8:00am EDT NeuBase Therapeutics Appoints Dr. Kia Motesharei Chief Business and Strategy Officer
May 14, 2021 12:30pm EDT NeuBase Therapeutics to Participate in Upcoming Investor Conferences in May 2021
May 13, 2021 4:05pm EDT NeuBase Therapeutics Reports Financial Results for the Second Quarter of Fiscal Year 2021
Apr 27, 2021 8:00am EDT NeuBase Therapeutics to Present at the B. Riley Securities’ Virtual Neuroscience Conference